DocGo (DCGO) Stock Price, News & Analysis

Company Overview

DocGo, Inc. is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging. The company also partners with public health agencies, employers, universities and event organizers to administer diagnostic testing services for COVID-19 and other infectious diseases. By integrating telehealth, remote patient monitoring and mobile diagnostic capabilities, DocGo aims to streamline access to care, reduce strain on traditional facilities and improve patient outcomes.

DocGo became a publicly traded company in June 2021 following a business combination with SPAC sponsor GigCapital3 Inc., trading on the Nasdaq under the ticker DCGO. Headquartered in Austin, Texas, the company has expanded its reach across multiple U.S. markets, including metropolitan areas in California, Florida, Texas and New York. DocGo’s on-demand approach leverages technology and logistics to enhance convenience, affordability and quality of care for both urban and rural communities.

Key Stats

• Today's Range: $0.60 to $0.64
• 50-Day Range: $0.52 to $0.78
• 52-Week Range: $0.49 to $1.78
• Volume: 337,353 shs
• Average Volume: 549,539 shs
• Market Capitalization: $62.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.38
• Consensus Rating: Hold

DocGo Stock Analysis - MarketRank™

DocGo scored higher than 54% of companies evaluated by MarketBeat, and ranked 441st out of 867 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.0 / 5
• Analyst Rating: Hold

Consensus Rating

DocGo has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

DocGo has a consensus price target of $2.38, representing about 276.7% upside from its current price of $0.63.

Amount of Analyst Coverage

DocGo has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for DocGo are expected to grow in the coming year, from ($0.12) to $0.05 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of DocGo is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DocGo is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DocGo has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.11% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 5.13.

Change versus previous month

Short interest in DocGo has recently decreased by 24.11%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DocGo does not currently pay a dividend.

Dividend Growth

DocGo does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for DocGo this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DocGo insiders have not sold or bought any company stock.

Percentage Held by Insiders

3.80% of the stock of DocGo is held by insiders.

Percentage Held by Institutions

56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 5/25/2026
• AGM 2026: 6/16/2026
• Next Earnings (Estimated): 8/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:DCGO
• CIK: 1822359
• Web: www.docgo.com
• Phone: 844-443-6246
• Fax: N/A
• Employees: 3,568
• Year Founded: N/A

Price Target and Rating

• Average Price Target for DocGo: $2.38
• High Price Target: $3.00
• Low Price Target: $1.00
• Potential Upside/Downside: +276.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.91)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$182.40 million
• Net Margins: -62.23%
• Pretax Margin: -62.77%
• Return on Equity: -44.09%
• Return on Assets: -29.14%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.79
• Quick Ratio: 1.79

Sales & Book Value

• Annual Sales: $322.20 million
• Price / Sales: 0.19
• Cash Flow: $0.06 per share
• Price / Cash Flow: 11.39
• Book Value: $1.13 per share
• Price / Book: 0.56

Miscellaneous

• Outstanding Shares: 98,750,000
• Free Float: 94,998,000
• Market Cap: $62.26 million
• Optionable: Optionable
• Beta: 1.02